Dr. Daniel Selchen, Head of the Division of Neurology at St. Michael’s Hospital, Toronto, hosts a discussion about the use of first- and second-line therapies in MS, identifying breakthrough disease, and when to switch treatments.
Roundtable participants:
Dr. Virender Bhan, Head of Neurology and Director of the MS clinic, Dalhousie University, Halifax, Nova Scotia; Dr. François Jacques, Director of the MS clinic, Gatineau, Quebec; and Dr. Paul Giacomini, Associate Director of the MS clinic, Montreal Neurological Institute, Montreal, Quebec.
Part 1:
Part 2: